These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 15668466)

  • 21. Role for inducible costimulator in control of Salmonella enterica serovar Typhimurium infection in mice.
    Vidric M; Bladt AT; Dianzani U; Watts TH
    Infect Immun; 2006 Feb; 74(2):1050-61. PubMed ID: 16428752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules.
    Smith DM; Bluestone JA; Jeyarajah DR; Newberg MH; Engelhard VH; Thistlethwaite JR; Woodle ES
    J Immunol; 1994 Aug; 153(3):1054-67. PubMed ID: 7913109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and function of the co-stimulator H4/ICOS on activated T cells of patients with rheumatoid arthritis.
    Okamoto T; Saito S; Yamanaka H; Tomatsu T; Kamatani N; Ogiuchi H; Uchiyama T; Yagi J
    J Rheumatol; 2003 Jun; 30(6):1157-63. PubMed ID: 12784384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ICOS costimulates invariant NKT cell activation.
    Kaneda H; Takeda K; Ota T; Kaduka Y; Akiba H; Ikarashi Y; Wakasugi H; Kronenberg M; Kinoshita K; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2005 Feb; 327(1):201-7. PubMed ID: 15629449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alloreactivity of ex vivo-expanded T cells is correlated with expansion and CD4/CD8 ratio.
    Mercier-Letondal P; Montcuquet N; Sauce D; Certoux JM; Jeanningros S; Ferrand C; Bonyhadi M; Tiberghien P; Robinet E
    Cytotherapy; 2008; 10(3):275-88. PubMed ID: 18418773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive phenotypic analysis of the gut intra-epithelial lymphocyte compartment: perturbations induced by acute reovirus 1/L infection of the gastrointestinal tract.
    Bharhani MS; Grewal JS; Peppler R; Enockson C; London L; London SD
    Int Immunol; 2007 Apr; 19(4):567-79. PubMed ID: 17369189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8+ cytotoxic T lymphocyte precursors.
    Hiraoka S; Takeuchi N; Bian Y; Nakahara H; Kogo M; Dunussi-Joannopoulos K; Wolf S; Ono S; Fujiwara H
    Int Immunol; 2005 Aug; 17(8):1071-9. PubMed ID: 16027141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
    Qiao M; Thornton AM; Shevach EM
    Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential expression of IL-2 receptor subunits on memory populations within CD4+ and CD8+ T cells.
    Taga K; Kasahara Y; Yachie A; Miyawaki T; Taniguchi N
    Immunology; 1991 Jan; 72(1):15-9. PubMed ID: 1900055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ICOS and B7 costimulatory molecule expression identifies activated cellular subsets in rheumatoid arthritis.
    Ruth JH; Rottman JB; Kingsbury GA; Coyle AJ; Haines GK; Pope RM; Koch AE
    Cytometry A; 2007 May; 71(5):317-26. PubMed ID: 17323353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD28- T lymphocytes. Antigenic and functional properties.
    Azuma M; Phillips JH; Lanier LL
    J Immunol; 1993 Feb; 150(4):1147-59. PubMed ID: 8381831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgene-enforced co-stimulation of CD4+ T cells leads to enhanced and sustained anti-tumor effector functioning.
    Chang L; Chang WC; McNamara G; Aguilar B; Ostberg JR; Jensen MC
    Cytotherapy; 2007; 9(8):771-84. PubMed ID: 17917884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-2 can support growth of CD8+ T cells but not CD4+ T cells of human IL-2 receptor beta-chain transgenic mice.
    Asano M; Ishida Y; Sabe H; Kondo M; Sugamura K; Honjo T
    J Immunol; 1994 Dec; 153(12):5373-81. PubMed ID: 7989743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.
    Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB
    J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cells for suicide gene therapy: activation, functionality and clinical relevance.
    Hollatz G; Grez M; Mastaglio S; Quaritsch R; Huenecke S; Ciceri F; Bonini C; Esser R; Klingebiel T; Kreuter J; Koehl U
    J Immunol Methods; 2008 Feb; 331(1-2):69-81. PubMed ID: 18155021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-2 responsiveness of CD4 and CD8 lymphocytes: further investigations with human IL-2Rbeta transgenic mice.
    Gesbert F; Moreau JL; Thèze J
    Int Immunol; 2005 Aug; 17(8):1093-102. PubMed ID: 16037071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signal requirement for induction of MHC-unrestricted antitumor cytotoxicity of human T cell CD4+/CD8+ subpopulations.
    Zhu HG; Klein-Franke A; Anderer FA
    Anticancer Res; 1994; 14(3A):953-61. PubMed ID: 8074498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of inducible co-stimulatory molecule (ICOS) on T-cell responses and protection against Mycobacterium tuberculosis infection.
    Nouailles G; Day TA; Kuhlmann S; Loewe D; Dorhoi A; Gamradt P; Hurwitz R; Jörg S; Pradl L; Hutloff A; Koch M; Kursar M; Kaufmann SH
    Eur J Immunol; 2011 Apr; 41(4):981-91. PubMed ID: 21337542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune recognition and effector function in subsets of CD4 T cells.
    Janeway CA; Yagi J; Rojo J; Portoles P; Carding S; Luqman M; Bottomly K
    Princess Takamatsu Symp; 1988; 19():193-208. PubMed ID: 2908353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response differences between human CD4(+) and CD8(+) T-cells during CD28 costimulation: implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging.
    Laux I; Khoshnan A; Tindell C; Bae D; Zhu X; June CH; Effros RB; Nel A
    Clin Immunol; 2000 Sep; 96(3):187-97. PubMed ID: 10964536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.